Weill Cornell Initiative for Maximizing Student Development
Weill Cornell Initiative for Maximizing Student Development
批准号:
9893726
负责人:
ETHEL CESARMAN
金额:
$51.8万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-04-30
关键词:
AddressBiomedical ResearchCareer ChoiceCareer ExplorationCommunitiesCommunity Health EducationCommunity NetworksDevelopmentDevelopment PlansDoctor of PhilosophyEducational CurriculumEducational process of instructingEventFacultyFosteringFundingGoalsHealthcareIndividualInstitutionInterventionInterviewLeadershipLifeMeasuresMedicineMemorial Sloan-Kettering Cancer CenterMentorsMentorshipMinority-Serving InstitutionNew York CityOutcomePerformancePreparationQualifyingReadinessResearchResourcesSchoolsScienceSelf EfficacySliceStreamStudentsTrainingUnderrepresented GroupsUnderrepresented Minoritybiomedical scientistcareercareer developmentcourse developmentdesigndoctoral studentexternshipgraduate school preparationhealth care disparityhigher educationinnovationlaboratory curriculumleadership developmentmembernext generationprogramsracial and ethnicrecruitself-renewalskillssocialsymposiumtoolunderrepresented minority student
中文摘要
项目摘要/摘要
威尔·康奈尔研究生院(WCGS)-威尔·康奈尔大学之间的教育和培训伙伴关系
医学和纪念斯隆-凯特琳癌症中心-是一个主要的博士生培训机构
生物医学科学。我们希望利用我们的培训能力(2.75亿美元的研究资金,340名毕业生
学校教职员工和330多名博士生),以提高我们吸引、留住和发展的比率
代表不足的少数民族(URM)博士生作为生物医学劳动力的领导者。要做到这一点
为了实现这一目标,我们提出了一项威尔·康奈尔国际管理发展学院的项目,目标如下:(1)吸引一批准备充分的
通过与当地和为少数群体服务的机构建立伙伴关系,让URM学生进入WCGS;(2)建立一个强大的、
通过早期启动计划,多方面地更新URM博士生和教师的自我更新社区
导师辅导和社交聚会;以及(3)为管理学院的学者提供领导力培训、专业技能
和网络成为各种生物医学和科学相关职业的领导者。WCGS为培训做好了准备
下一代URM生物医学科学家和我们相信,通过威尔·康奈尔大学的IMSD,我们
可以培养源源不断的训练有素的博士人才,既能实现多元化,又能为
生物医学工作人员。
英文摘要
Project Summary/Abstract
The Weill Cornell Graduate School (WCGS)—an educational and training partnership between Weill Cornell
Medicine and Memorial Sloan Kettering Cancer Center—is a premier institution for PhD training in the
biomedical sciences. We look to leverage our training capacity ($275 million in research funding, 340 graduate
school faculty, and over 330 PhD students) to increase our rates of attracting, retaining, and developing
underrepresented minority (URM) doctoral students as leaders in the biomedical workforce. To accomplish this
goal, we propose a Weill Cornell IMSD program with the following aims: (1) Attract a pool of well-prepared
URM students to WCGS through partnerships with local and minority-serving institutions; (2) Build a robust,
self-renewing community of URM doctoral students and faculty through an early start program, multifaceted
mentorship, and social gatherings; and (3) Equip IMSD scholars with leadership training, professional skills
and networks to be leaders in a variety of biomedical and science-related careers. WCGS is primed for training
the next generation of URM biomedical scientists and we are confident that through the Weill Cornell IMSD, we
can develop a steady stream of well-trained PhD's that will both diversify and bring innovation to the
biomedical workforce.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
-
批准号:10592130
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2023
-
负责人:ETHEL CESARMAN
-
依托单位:
Next-Gen Oncopathology Program
-
批准号:10676213
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10416778
-
项目类别:
-
资助金额:$65.74万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
-
批准号:10642906
-
项目类别:
-
资助金额:$61.26万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10541734
-
项目类别:
-
资助金额:$86.4万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
B cell determinants of EBV latency
-
批准号:10701826
-
项目类别:
-
资助金额:$82.78万
-
财政年份:2022
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10228431
-
项目类别:
-
资助金额:$120.03万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10616708
-
项目类别:
-
资助金额:$117.81万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
-
批准号:10398963
-
项目类别:
-
资助金额:$117.86万
-
财政年份:2021
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10737765
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10397107
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10532587
-
项目类别:
-
资助金额:$23.9万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10617688
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
-
批准号:10165675
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2020
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:10405468
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10671507
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Role of novel onco-histone mutations in B-cell malignancies
-
批准号:10454959
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Weill Cornell Initiative for Maximizing Student Development
-
批准号:10618368
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
The 22nd International Conference on Kaposi's sarcoma-associated herpesvirus and Related Agents
-
批准号:9763269
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2019
-
负责人:ETHEL CESARMAN
-
依托单位:
Targeting vFLIP for the treatment of KSHV-associated malignancies
-
批准号:8433482
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2011
-
负责人:ETHEL CESARMAN
-
依托单位:
海外基金